ORCID as entered in ROS

Select Publications
2021, 'Waitlist and post-transplant outcomes for eisenmenger syndrome: A comparison of transplant strategies', Journal of Heart and Lung Transplantation, 40, pp. 841 - 849, http://dx.doi.org/10.1016/j.healun.2021.04.005
,2021, 'SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants', PLoS Medicine, 18, http://dx.doi.org/10.1371/journal.pmed.1003656
,2021, 'Diffusing Capacity for Carbon Monoxide (DLCO): Association with long-term outcomes after Lung Transplantation in a 20-year longitudinal study.', European Respiratory Journal, 59, pp. 2003639, http://dx.doi.org/10.1183/13993003.03639-2020
,2021, 'Recovery after COVID-19. Persistent symptoms beyond acute infection', Respiratory Medicine Today, 6, pp. 20 - 22, https://respiratory.medicinetoday.com.au/2021/april/regular-series/recovery-after-covid-19-persistent-symptoms-beyond-acute-infection
,2021, 'Identifying the association between tacrolimus exposure and toxicity in heart and lung transplant recipients: A systematic review', Transplantation Reviews, 35, http://dx.doi.org/10.1016/j.trre.2021.100610
,2021, 'Persistent symptoms up to four months after community and hospital- managed SARS- CoV- 2 infection', Medical Journal of Australia, http://dx.doi.org/10.5694/mja2.50963
,2021, 'Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection', , http://dx.doi.org/10.1101/2021.06.01.21257759
,2021, 'Limited recovery from post-acute sequelae of SARS-CoV-2 (PASC) at eight months in a prospective cohort', , http://dx.doi.org/10.1101/2021.03.29.21254211
,2020, 'SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants', , http://dx.doi.org/10.1101/2020.12.19.20248567
,2020, 'Autoantibodies against type I IFNs in patients with life-threatening COVID-19', Science, 370, pp. eabd4585, http://dx.doi.org/10.1126/science.abd4585
,2020, 'Inborn errors of type I IFN immunity in patients with life-threatening COVID-19', Science, 370, pp. eabd4570, http://dx.doi.org/10.1126/science.abd4570
,2020, 'Eosinophils in transbronchial biopsies: a predictor of chronic lung allograft dysfunction and reduced survival after lung transplantation - a retrospective single-center cohort study.', Transpl Int, 34, pp. 62 - 75, http://dx.doi.org/10.1111/tri.13760
,2020, 'Approaches to the Management of Sensitized Lung Transplant Candidates: Findings from an International Survey', The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 39, pp. S315, http://dx.doi.org/10.1016/j.healun.2020.01.709
,2020, 'Continuation of mTOR Inhibition in LAM Patients Listed for Lung Transplant is Safe', The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 39, pp. S324, http://dx.doi.org/10.1016/j.healun.2020.01.334
,2020, 'Diffusing Capacity for Carbon Monoxide (DLCO) Trajectory in CLAD Phenotypes', The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 39, pp. S306, http://dx.doi.org/10.1016/j.healun.2020.01.685
,2019, 'COPD treatment choices based on blood eosinophils: Are we there yet?', Breathe, 15, pp. 318 - 323, http://dx.doi.org/10.1183/20734735.0254-2019
,2019, 'Tacrolimus exposure early after lung transplantation and exploratory associations with acute cellular rejection', European Journal of Clinical Pharmacology, 75, pp. 879 - 888, http://dx.doi.org/10.1007/s00228-019-02658-5
,2019, 'Diffusing Capacity for Carbon Monoxide (DLCO): A Predictor of CLAD and Death after Lung Transplantation in a 20-Year Longitudinal Study', JOURNAL OF HEART AND LUNG TRANSPLANTATION, 38, pp. S15 - S15, http://dx.doi.org/10.1016/j.healun.2019.01.021
,2019, 'A Combination of Delayed Gastric Emptying and Gastroesophageal Reflux Disease is Associated with Worse Outcomes in Lung Transplantation', JOURNAL OF HEART AND LUNG TRANSPLANTATION, 38, pp. S121 - S121, http://dx.doi.org/10.1016/j.healun.2019.01.285
,2018, 'Eosinophils on Transbronchial Biopsies Are Predictive of Reduced Survival After Lung Transplantation', JOURNAL OF HEART AND LUNG TRANSPLANTATION, 37, pp. S111 - S111, http://dx.doi.org/10.1016/j.healun.2018.01.265
,2017, 'Chest pain and recurrent chylothorax: An unusual presentation of malignant pleural mesothelioma', Respirology Case Reports, 5, pp. 1 - 3, http://dx.doi.org/10.1002/rcr2.250
,2016, 'Donor-derived tuberculosis (TB): isoniazid-resistant TB transmitted from a lung transplant donor with inadequately treated latent infection', Transplant Infectious Disease, 18, pp. 782 - 784, http://dx.doi.org/10.1111/tid.12580
,2016, 'Trough Blood Concentrations Are an Accurate Indicator of Tacrolimus Exposure Early Post Lung Transplantation', JOURNAL OF HEART AND LUNG TRANSPLANTATION, 35, pp. S238 - S238, http://dx.doi.org/10.1016/j.healun.2016.01.674
,2016, 'A rare cause of intrathoracic mass', Medical Journal of Australia, 204, pp. 107, http://dx.doi.org/10.5694/MJA15.01093
,2016, 'A rare case of everolimus-induced pulmonary alveolar proteinosis', Journal of Heart and Lung Transplantation, 35, pp. 147 - 148, http://dx.doi.org/10.1016/j.healun.2015.10.001
,2016, 'Quantitation of the Effect of Azole Antifungals on Tacrolimus Clearance', JOURNAL OF HEART AND LUNG TRANSPLANTATION, 35, pp. S236 - S236, http://dx.doi.org/10.1016/j.healun.2016.01.670
,2015, 'Trough Blood Levels Are a Poor Marker of Tacrolimus Exposure in Lung Transplantation', JOURNAL OF HEART AND LUNG TRANSPLANTATION, 34, pp. S55 - S55, http://dx.doi.org/10.1016/j.healun.2015.01.137
,2015, 'A rare case of everolimus-induced pulmonary alveolar proteinosis', Journal of Heart and Lung Transplantation, http://dx.doi.org/10.1016/j.healun.2015.10.001
,2014, 'Laryngeal aspergilloma: A complication of inhaled fluticasone therapy for asthma', Respirology Case Reports, 2, pp. 123 - 125, http://dx.doi.org/10.1002/rcr2.70
,